HERPES MEDICATION DOES NOT REDUCE RISK OF HIV INFECTION IN INDIVIDUALS WITH HSV-2, INTERNATIONAL STUDY FINDS
February 05, 2008
February 05, 2008
SEATTLE, Feb. 5 -- The University of Washington issued the following news release:
An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV. Researchers had hoped that acyclovir's ability to suppress the her . . .
An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV. Researchers had hoped that acyclovir's ability to suppress the her . . .